Annual Shareholders Equity
$362.50 M
-$78.67 M-17.83%
31 December 2023
Summary:
NovoCure Limited annual stockholders equity is currently $362.50 million, with the most recent change of -$78.67 million (-17.83%) on 31 December 2023. During the last 3 years, it has fallen by -$114.03 million (-23.93%). NVCR annual shareholders equity is now -23.93% below its all-time high of $476.53 million, reached on 31 December 2020.NVCR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$360.78 M
-$969.00 K-0.27%
30 September 2024
Summary:
NovoCure Limited quarterly stockholders equity is currently $360.78 million, with the most recent change of -$969.00 thousand (-0.27%) on 30 September 2024. Over the past year, it has dropped by -$32.92 million (-8.36%). NVCR quarterly shareholders equity is now -24.29% below its all-time high of $476.53 million, reached on 31 December 2020.NVCR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVCR Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.8% | -8.4% |
| 3 y3 years | -23.9% | -12.7% |
| 5 y5 years | +222.9% | +89.5% |
NVCR Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -23.9% | at low | -19.0% | +0.4% |
| 5 y | 5 years | -23.9% | +222.9% | -24.3% | +89.5% |
| alltime | all time | -23.9% | +270.4% | -24.3% | +268.6% |
NovoCure Limited Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $360.78 M(-0.3%) |
| June 2024 | - | $361.75 M(+0.7%) |
| Mar 2024 | - | $359.36 M(-0.9%) |
| Dec 2023 | $362.50 M(-17.8%) | $362.50 M(-7.9%) |
| Sept 2023 | - | $393.70 M(-5.3%) |
| June 2023 | - | $415.68 M(-3.8%) |
| Mar 2023 | - | $432.15 M(-2.0%) |
| Dec 2022 | $441.17 M(+7.5%) | $441.17 M(-0.9%) |
| Sept 2022 | - | $445.40 M(+0.8%) |
| June 2022 | - | $441.67 M(+1.3%) |
| Mar 2022 | - | $435.88 M(+6.2%) |
| Dec 2021 | $410.49 M(-13.9%) | $410.49 M(-0.6%) |
| Sept 2021 | - | $413.16 M(+4.0%) |
| June 2021 | - | $397.27 M(+6.8%) |
| Mar 2021 | - | $372.13 M(-21.9%) |
| Dec 2020 | $476.53 M(+118.8%) | $476.53 M(+55.2%) |
| Sept 2020 | - | $307.04 M(+14.6%) |
| June 2020 | - | $267.82 M(+10.7%) |
| Mar 2020 | - | $241.95 M(+11.1%) |
| Dec 2019 | $217.79 M | $217.79 M(+14.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | $190.37 M(+19.8%) |
| June 2019 | - | $158.91 M(+25.7%) |
| Mar 2019 | - | $126.39 M(+12.6%) |
| Dec 2018 | $112.26 M(-1.1%) | $112.26 M(-2.3%) |
| Sept 2018 | - | $114.94 M(+2.5%) |
| June 2018 | - | $112.08 M(+5.6%) |
| Mar 2018 | - | $106.12 M(-6.6%) |
| Dec 2017 | $113.56 M(-20.2%) | $113.56 M(-2.7%) |
| Sept 2017 | - | $116.69 M(-0.7%) |
| June 2017 | - | $117.55 M(-8.8%) |
| Mar 2017 | - | $128.90 M(-9.4%) |
| Dec 2016 | $142.34 M(-43.2%) | $142.34 M(-10.0%) |
| Sept 2016 | - | $158.24 M(-15.2%) |
| June 2016 | - | $186.65 M(-15.3%) |
| Mar 2016 | - | $220.43 M(-12.1%) |
| Dec 2015 | $250.82 M(+156.3%) | $250.82 M(+106.9%) |
| Sept 2015 | - | $121.22 M(-16.0%) |
| June 2015 | - | $144.31 M(+47.4%) |
| Dec 2014 | $97.88 M(-43.0%) | $97.88 M |
| Dec 2013 | $171.78 M | - |
FAQ
- What is NovoCure Limited annual stockholders equity?
- What is the all time high annual shareholders equity for NovoCure Limited?
- What is NovoCure Limited annual shareholders equity year-on-year change?
- What is NovoCure Limited quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for NovoCure Limited?
- What is NovoCure Limited quarterly shareholders equity year-on-year change?
What is NovoCure Limited annual stockholders equity?
The current annual shareholders equity of NVCR is $362.50 M
What is the all time high annual shareholders equity for NovoCure Limited?
NovoCure Limited all-time high annual stockholders equity is $476.53 M
What is NovoCure Limited annual shareholders equity year-on-year change?
Over the past year, NVCR annual stockholders equity has changed by -$78.67 M (-17.83%)
What is NovoCure Limited quarterly stockholders equity?
The current quarterly shareholders equity of NVCR is $360.78 M
What is the all time high quarterly shareholders equity for NovoCure Limited?
NovoCure Limited all-time high quarterly stockholders equity is $476.53 M
What is NovoCure Limited quarterly shareholders equity year-on-year change?
Over the past year, NVCR quarterly stockholders equity has changed by -$32.92 M (-8.36%)